MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Tuesday, June 21, 2016

12:30pm-2:00pm
α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients

G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease

H. Sumikura, J. Fujigasaki, Y. Nakano, A. Uchino, Y. Saito, H. Mochizuki, S. Murayama (Tokyo, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
"Are patients with familial ET distinct from those with sporadic ET? Insight from 250 patients"

M. Manjunath, A. Lenka, K. Jhunjhunwala, K.S. Bhalsing, P.K. Pal (Bengaluru, India)

Tremor  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
DYT2 screening in early-onset isolated dystonia in Italy

C. Reale, F. Invernizzi, M. Carecchio, S. Petrucci, G. Zorzi, F. Zibordi, M. Ginevrino, E.M. Valente, N. Nardocci, B. Garavaglia (Milan, Italy)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families

I.A. Meijer, L.J. Azcona, H. Darvish, C. Paisán-Ruiz (New York, NY, USA)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
1 to 40 years later: Delayed effects of brain radiation presenting as parkinsonism

R. Mehanna, J. Jimenez-Shahed, I. Itin, R. Mehanna (Houston, TX, USA)

Drug-induced movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A 12-month, 2-arm, 2-period, randomized, controlled trial of a digital solution for the management of Parkinson’s disease (PD): Rationale and study design

S. Papapetropoulos, G. Mitsi (Boston, MA, USA)

Technology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A comparative study of clinical profile of patients of drug induced parkinsonism with idiopathic Parkinson’s disease

S. Kushwaha, R. Mistry, A. Anthony, S. Khurana (Delhi, India)

Hyperkinetic Movement Disorders, RLS, Sleep
12:30pm-2:00pm
A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease

J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor (Herts, United Kingdom)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
  • 1
  • 2
  • 3
  • …
  • 48
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley